Skip to main navigation Skip to search Skip to main content

Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease

  • Toshiki Tezuka
  • , Daisuke Taniguchi
  • , Mariko Sano
  • , Tomoyo Shimada
  • , Yutaka Oji
  • , Taiji Tsunemi
  • , Aya Ikeda
  • , Yuanzhe Li
  • , Hiroyo Yoshino
  • , Jun Ogata
  • , Kahori Shiba-Fukushima
  • , Manabu Funayama
  • , Kenya Nishioka
  • , Yuzuru Imai
  • , Nobutaka Hattori

Research output: Contribution to journal › Article › peer-review

Abstract

Missense variants in leucine-rich repeat kinase 2 (LRRK2) lead to familial and sporadic Parkinson’s disease (PD). The pathological features of PD patients with LRRK2 variants differ. Here, we report an autopsy case harboring the LRRK2 G2385R, a risk variant for PD occurring mainly in Asian populations. The patient exhibited levodopa-responsive parkinsonism at the early stage and visual hallucinations at the advanced stage. The pathological study revealed diffuse Lewy bodies with neurofibrillary tangles, amyloid plaques, and mild signs of neuroinflammation. Biochemically, detergent-insoluble phospho-α-synuclein was accumulated in the frontal, temporal, entorhinal cortexes, and putamen, consistent with the pathological observations. Elevated phosphorylation of Rab10, a substrate of LRRK2, was also prominent in various brain regions. In conclusion, G2385R appears to increase LRRK2 kinase activity in the human brain, inducing a deleterious brain environment that causes Lewy body pathology.

Original languageEnglish
Article number97
Journalnpj Parkinson's Disease
Volume8
Issue number1
DOIs
Publication statusPublished - 2022 Dec

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Fingerprint

Dive into the research topics of 'Pathophysiological evaluation of the LRRK2 G2385R risk variant for Parkinson’s disease'. Together they form a unique fingerprint.

Cite this